PLAU and metabolic dysfunction-associated steatohepatitis: Serum ALT/AST (Figure 1E) and pericellular fibrosis (Figures 1F and G) were similarly elevated in both MUP-uPA and HFHC-fed Wt, indicative of advanced MASH progression.